Oestrogen-related receptors in breast cancer: Control of cellular metabolism and beyond

Nature Reviews Cancer

Volumn 13, Issue 1, 2013, Pages 27-36

  Deblois, Geneviève ^a   Giguère, Vincent ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; ESTROGEN RELATED RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR BETA; ESTROGEN RELATED RECEPTOR GAMMA; GLUTAMINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTATE DEHYDROGENASE; MANGANESE SUPEROXIDE DISMUTASE; MYC PROTEIN; OSTEOPROTEGERIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; PROGESTERONE RECEPTOR; REACTIVE OXYGEN METABOLITE; STEROID RECEPTOR COACTIVATOR 3; TAMOXIFEN; UNCLASSIFIED DRUG; VASCULOTROPIN; WNT11 PROTEIN;

AEROBIC METABOLISM; BINDING SITE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER PROGNOSIS; CELL FATE; CELL GROWTH; CELL METABOLISM; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ASSESSMENT; DOWN REGULATION; ENERGY METABOLISM; ESTROGEN SYNTHESIS; GENE AMPLIFICATION; GENE CONTROL; GLYCOLYSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIGAND BINDING; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; MOLECULAR INTERACTION; NONHUMAN; NUCLEAR REPROGRAMMING; ONCOGENE MYC; OXIDATIVE PHOSPHORYLATION; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; REVIEW; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TUMOR LOCALIZATION; UPREGULATION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; RECEPTORS, ESTROGEN;

EID: 84871715437     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc3396     Document Type: Review

References (104)

1. Jordan, V. C. & O'Malley, B. W. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer. J. Clin. Oncol. 25, 5815-5824 (2007).
2. Jordan, V. C. A century of deciphering the control mechanisms of sex steroid action in breast and prostate cancer: the origins of targeted therapy and chemoprevention. Cancer Res. 69, 1243-1254 (2009).
3. Giguère, V., Yang, N., Segui, P. & Evans, R. M. Identification of a new class of steroid hormone receptors. Nature 331, 91-94 (1988).
4. Tremblay, A. M. & Giguère, V. The NR3B subgroup: an ovERRview. Nucl. Recept. Signal. 5, e009 (2007).
5. Giguère, V. To ERR in the estrogen pathway. Trends Endocrinol. Metab. 13, 220-225 (2002).
6. Giguère, V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr. Rev. 29, 677-696 (2008).
7. Villena, J. A. & Kralli, A. ERRα: a metabolic function for the oldest orphan. Trends Endocrinol. Metab. 19, 269-276 (2008).
8. Hong, H., Yang, L. & Stallcup, M. R. Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3. J. Biol. Chem. 274, 22618-22626 (1999).
9. Heck, S. et al. Estrogen-related receptor α expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma. Cancer Res. 69, 5186-5193 (2009).
10. Xie, W. et al. Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2. Mol. Endocrinol. 13, 2151-2162 (1999).
11. Zhang, Z. & Teng, C. T. Estrogen receptor-related receptor α1 interacts with coactivator and constitutively activates the estrogen response elements of the human lactoferrin gene. J. Biol. Chem. 275, 20837-20846 (2000).
12. Percharde, M. et al. Ncoa3 functions as an essential Esrrb coactivator to sustain embryonic stem cell self-renewal and reprogramming. Genes Dev. 26, 2286-2298 (2012).
13. Gaillard, S., Dwyer, M. A. & McDonnell, D. P. Definition of the molecular basis for estrogen receptor-related receptor-α-cofactor interactions. Mol. Endocrinol. 21, 62-76 (2007).
14. Huss, J. M., Kopp, R. P. & Kelly, D. P. Peroxisome proliferator-activated receptor coactivator-1α (PGC-1α) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-α and-γ. Identification of novel leucine-rich interaction motif within PGC-1α. J. Biol. Chem. 277, 40265-40274 (2002).
15. Kamei, Y. et al. PPARγ coactivator 1β/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. Proc. Natl Acad. Sci. USA 100, 12378-12383 (2003).
16. Laganière, J. et al. A polymorphic autoregulatory hormone response element in the human estrogen related receptor α (ERRα) promoter dictates PGC-1α control of ERRα expression. J. Biol. Chem. 279, 18504-18510 (2004).
17. Schreiber, S. N., Knutti, D., Brogli, K., Uhlmann, T. & Kralli, A. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor ERRα. J. Biol. Chem. 278, 9013-9018 (2003).
18. Ariazi, E. A., Kraus, R. J., Farrell, M. L., Jordan, V. C. & Mertz, J. E. Estrogen-related receptor α1 transcriptional activities are regulated in part via the ErbB2/HER2 signaling pathway. Mol. Cancer Res. 5, 71-85 (2007).
19. Barry, J. B. & Giguère, V. Epidermal growth factor-induced signaling in breast cancer cells results in selective target gene activation by orphan nuclear receptor estrogen-related receptor α. Cancer Res. 65, 6120-6129 (2005).
20. Tremblay, A. M., Dufour, C. R., Ghahremani, M., Reudelhuber, T. L. & Giguère, V. Physiological genomics identifies estrogen-related receptor α as a regulator of renal sodium and potassium homeostasis and the renin-angiotensin pathway. Mol. Endocrinol. 24, 22-32 (2010).
21. Tremblay, A. M., Wilson, B. J., Yang, X. J. & Giguère, V. Phosphorylation-dependent sumoylation regulates ERRα and γ transcriptional activity through a synergy control motif. Mol. Endocrinol. 22, 570-584 (2008).
22. Wilson, B. J., Tremblay, A. M., Deblois, G., Sylvain-Drolet, G. & Giguere, V. An acetylation switch modulates the transcriptional activity of estrogen-related recetpor α. Mol. Endocrinol. 24, 1349-1358 (2010).
23. Mootha, V. K. et al. ERRα and GABPAα/β specify PGC-1α-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl Acad. Sci. USA 101, 6570-6575 (2004).
24. Charest-Marcotte, A. et al. The homeobox protein Prox1 is a negative modulator of ERRα/PGC-1α bioenergetic functions. Genes Dev. 24, 537-542 (2010).
25. Dufour, C. R. et al. Genomic convergence among ERRα, Prox1 and Bmal1 in the control of metabolic clock outputs. PLoS Genet. 7, e1002143 (2011).
26. Dufour, C. R. et al. Genome-wide orchestration of cardiac functions by orphan nucler receptors ERRα and γ. Cell Metab. 5, 345-356 (2007).
27. Alaynick, W. A. et al. ERRγ directs and maintains the transition to oxidative metabolism in the post-natal heart. Cell Metab. 6, 16-24 (2007).
28. Sonoda, J. et al. Nuclear receptor ERRα and coactivator PGC-1β are effectors of IFN-γ induced host defense. Genes Dev. 21, 1909-1920 (2007).
29. Eichner, L. J. & Giguère, V. Estrogen-related receptors (ERRs): a new dawn in the control of mitochondrial gene networks. Mitochondrion 11, 544-552 (2011).
30. Luo, J. et al. Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor α. Mol. Cell. Biol. 23, 7947-7956 (2003).
31. Carrier, J. C., Deblois, G., Champigny, C., Levy, E. & Giguère, V. Estrogen related-receptor α (ERRα) is a transcriptional regulator of apolipoprotein A-IV and controls lipid handling in the intestine. J. Biol. Chem. 279, 52052-52058 (2004).
32. Villena, J. A., Hock, M. B., Giguère, V. & Kralli, A. Orphan nuclear receptor ERRα is essential for adaptive thermogenesis. Proc. Natl Acad. Sci. USA 104, 1418-1423 (2007).
33. Huss, J. M. et al. The nuclear receptor ERRα is required for the bioenergetic and functional adaption to cardiac pressure overload. Cell Metab. 6, 25-37 (2007).
34. Michalek, R. D. et al. Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation. Proc. Natl Acad. Sci. USA 108, 18348-18353 (2011).
35. Vega, R. B. & Kelly, D. P. A role for estrogen-related receptor α in the control of mitochondrial fatty acid β-oxidation during brown adipocyte differentiation. J. Biol. Chem. 272, 31693-31699 (1997).
36. Morganstein, D. L. et al. Human fetal mesenchymal stem cells differentiate into brown and white adipocytes: a role for ERRα in human UCP1 expression. Cell Res. 20, 434-444 (2010).
37. Murray, J. & Huss, J. M. Estrogen-related receptor α regulates skeletal myocyte differentiation via modulation of the ERK MAP kinase pathway. Am. J. Physiol. Cell Physiol. 301, C630-C645 (2011).
38. D'Errico, I. et al. Peroxisome proliferator-activated receptor-γ coactivator 1-α (PGC1α) is a metabolic regulator of intestinal epithelial cell fate. Proc. Natl Acad. Sci. USA 108, 6603-6608 (2011).
39. Bonnelye, E., Merdad, L., Kung, V. & Aubin, J. E. The orphan nuclear estrogen receptor-related receptor α (ERRα) is expressed throughout osteoblast differentiation and regulates bone formation in vitro. J. Cell Biol. 153, 971-984 (2001).
40. Luo, J., Sladek, R., Bader, J.-A., Rossant, J. & Giguère, V. Placental abnormalities in mouse embryos lacking orphan nuclear receptor ERRβ. Nature 388, 778-782 (1997).
41. Tremblay, G. B. et al. Diethylstilbestrol regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERRβ. Genes Dev. 15, 833-838 (2001).
42. Chen, J. & Nathans, J. Estrogen-related receptor β/NR3B2 controls epithelial cell fate and endolymph production by the stria vascularis. Dev. Cell 13, 325-337 (2007).
43. Ivanova, N. et al. Dissecting self-renewal in stem cells with RNA interference. Nature 442, 533-538 (2006).
44. Feng, B. et al. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nature Cell Biol. 11, 197-203 (2009).
45. Chen, X. et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133, 1106-11017 (2008).
46. Kumar, P. & Mendelson, C. R. Estrogen-related receptor γ (ERRγ) mediates oxygen-dependent induction of aromatase (CYP19) gene expression during human trophoblast differentiation. Mol. Endocrinol. 25, 1513-1526 (2011).
47. Kubo, M. et al. Modulation of adipogenesis-related gene expression by estrogen-related receptor γ during adipocytic differentiation. Biochim. Biophys. Acta 1789, 71-77 (2009).
48. Vanacker, J. M., Delmarre, C., Guo, X. & Laudet, V. Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related α. Cell Growth Differ. 9, 1007-1014 (1998).
49. Yang, C., Zhou, D. & Chen, S. Modulation of aromatase expression in the breast tissue by ERRα-1 orphan receptor. Cancer Res. 58, 5695-5700 (1998).
50. Yang, N., Shigeta, H., Shi, H. P. & Teng, C. T. Estrogen-related receptor, hERR1, modulates estrogen receptor-mediated response of human lactoferrin gene promoter. J. Biol. Chem. 271, 5795-5804 (1996).
51. Lu, D., Kiriyama, Y., Lee, K. Y. & Giguère, V. Transcriptional regulation of the estrogen-inducible pS2 beast cancer marker gene by the ERR family of orphan nuclear receptors. Cancer Res. 61, 6755-6761 (2001).
52. Sladek, R., Bader, J.-A. & Giguère, V. The orphan nuclear receptor estrogen-related receptor α is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene. Mol. Cell. Biol. 17, 5400-5409 (1997).
53. Deblois, G. et al. Genome-wide identification of direct target genes implicates estrogen-related receptor α as a determinant of breast cancer heterogeneity. Cancer Res. 69, 6149-6157 (2009).
54. Stein, R. A. et al. Estrogen-related receptor α is critical for the growth of estrogen receptor-negative breast cancer. Cancer Res. 68, 8805-8812 (2008).
55. Chisamore, M. J., Wilkinson, H. A., Flores, O. & Chen, J. D. Estrogen-related receptor-α antagonist inhibits both estrogen receptor-positive and estrogen receptor-negative breast tumor growth in mouse xenografts. Mol. Cancer Ther. 8, 672-681 (2009).
56. Ariazi, E. A., Clark, G. M. & Mertz, J. E. Estrogen-related receptor α and estrogen-related receptor γ associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Res. 62, 6510-6518 (2002).
57. Jarzabek, K. et al. The significance of the expression of ERRα as a potential biomarker in breast cancer. J. Steroid Biochem. Mol. Biol. 113, 127-133 (2009).
58. Suzuki, T. et al. Estrogen-related receptor α in human breast carcinoma as a potent prognostic factor. Cancer Res. 64, 4670-4676 (2004).
59. Chang, C. Y. et al. The metabolic regulator ERRα, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancer. Cancer Cell 20, 500-510 (2011).
60. Ijichi, N. et al. Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer. J. Steroid Biochem. Mol. Biol. 123, 1-7 (2011).
61. Riggins, R. B. et al. ERRγ mediates tamoxifen resistance in novel models of invasive lobular breast cancer. Cancer Res. 68, 8908-8917 (2008).
62. Bianco, S. et al. Modulating estrogen receptor-related receptor-α activity inhibits cell proliferation. J. Biol. Chem. 284, 23286-23292 (2009).
63. Deblois, G. et al. Transcriptional control of the ERBB2 amplicon by ERRα and PGC-1β promotes mammary gland tumorigenesis. Cancer Res. 70, 10277-10287 (2010).
64. Fradet, A. et al. Dual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin. Cancer Res. 71, 5728-5738 (2011).
65. Dwyer, M. A. et al. WNT11 expression is induced by estrogen-related receptor α and β-catenin and acts in an autocrine manner to increase cancer cell migration. Cancer Res. 70, 9298-9308 (2010).
66. Stein, R. A., Gaillard, S. & McDonnell, D. P. Estrogen-related receptor α induces the expression of vascular endothelial growth factor in breast cancer cells. J. Steroid Biochem. Mol. Biol. 114, 106-1012 (2009).
67. Zhao, Y. et al. MiR-137 targets estrogen-related receptor α and impairs the proliferative and migratory capacity of breast cancer cells. PLoS ONE 7, e39102 (2012).
68. Eichner, L. J. et al. mir-378* mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway. Cell Metab. 12, 352-361 (2010).
69. Tiraby, C., Hazen, B. C., Gantner, M. L. & Kralli, A. Estrogen-related receptor γ promotes mesenchymal-to-epithelial transition and suppresses breast tumor growth. Cancer Res. 71, 2518-2528 (2011).
70. Cairns, R. A., Harris, I. S. & Mak, T. W. Regulation of cancer cell metabolism. Nature Rev. Cancer 11, 85-95 (2011).
71. Warburg, O. On respiratory impairment in cancer cells. Science 124, 269-270 (1956).
72. Koppenol, W. H., Bounds, P. L. & Dang, C. V. Otto Warburg's contributions to current concepts of cancer metabolism. Nature Rev. Cancer 11, 325-337 (2011).
73. Tennessen, J. M., Baker, K. D., Lam, G., Evans, J. & Thummel, C. S. The Drosophila estrogen-related receptor directs a metabolic switch that supports developmental growth. Cell Metab. 13, 139-148 (2011).
74. Zhu, A., Lee, D. & Shim, H. Metabolic positron emission tomography imaging in cancer detection and therapy response. Semin. Oncol. 38, 55-69 (2011).
75. Salem, A. F., Whitaker-Menezes, D., Howell, A., Sotgia, F. & Lisanti, M. P. Mitochondrial biogenesis in epithelial cancer cells promotes breast cancer tumor growth and confers autophagy resistance. Cell Cycle 15 Oct 2012 [epub ahead of print].
76. Schreiber, S. N. et al. The estrogen-related receptor α (ERRα) functions in PPARγ coactivator 1α (PGC-1α)- induced mitochondrial biogenesis. Proc. Natl Acad. Sci. USA 101, 6472-6477 (2004).
77. Chen, E. I. et al. Adaptation of energy metabolism in breast cancer brain metastases. Cancer Res. 67, 1472-1486 (2007).
78. Dang, C. V. Links between metabolism and cancer. Genes Dev. 26, 877-890 (2012).
79. Chan, C. H. et al. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis. Cell 149, 1098-1111 (2012).
80. Zhao, Y. H. et al. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth. Oncogene 28, 3689-3701 (2009).
81. Menendez, J. A. Fine-tuning the lipogenic/lipolytic balance to optimize the metabolic requirements of cancer cell growth: molecular mechanisms and therapeutic perspectives. Biochim. Biophys. Acta 1801, 381-391 (2010).
82. Vazquez-Martin, A., Ortega-Delgado, F. J., Fernandez-Real, J. M. & Menendez, J. A. The tyrosine kinase receptor HER2 (erbB-2): from oncogenesis to adipogenesis. J. Cell Biochem. 105, 1147-1152 (2008).
83. Klimcakova, E. et al. PGC-1α promotes the growth of ErbB2/Neu-induced mammary tumors by regulating nutrient supply. Cancer Res. 72, 1538-1546 (2012).
84. Lin, C. Y. et al. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151, 56-67 (2012).
85. Nie, Z. et al. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151, 68-79 (2012).
86. Davidson, S. M. & Vander Heiden, M. G. METabolic adaptations in the tumor MYCroenvironment. Cell Metab. 15, 131-133 (2012).
87. Dang, C. V., Kim, J. W., Gao, P. & Yustein, J. The interplay between MYC & HIF in cancer. Nature Rev. Cancer 8, 51-56 (2008).
88. Cai, Q., Lin, T., Kamarajugadda, S. & Lu, J. Regulation of glycolysis and the Warburg effect by estrogen-related receptors. Oncogene 4 Jun 2012 (doi:10.1038/onc.2012.221).
89. Osborne, C. K. et al. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J. Natl Canc Inst. 95, 353-361 (2003).
90. Hurtado, A. et al. Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. Nature 456, 663-666 (2008).
91. Greschik, H., Flaig, R., Renaud, J. P. & Moras, D. Structural basis for the deactivation of the estrogen-related receptor γ by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity. J. Biol. Chem. 279, 33639-33646 (2004).
92. Kallen, J. et al. Crystal structure of human estrogen-related receptor α in complex with a synthetic inverse agonist reveals its novel molecular mechanism. J. Biol. Chem. 282, 23231-23239 (2007).
93. Wang, L. et al. X-ray crystal structures of the estrogen-related receptor-γ ligand binding domain in three functional states reveal the molecular basis of small molecule regulation. J. Biol. Chem. 281, 37773-37781 (2006).
94. Tremblay, G. B., Bergeron, D. & Giguère, V. 4-hydroxytamoxifen is an isoform-specific inhibitor of orphan estrogen-receptor-related (ERR) nuclear receptors β and γ. Endocrinology 142, 4572-4575 (2001).
95. Coward, P., Lee, D., Hull, M. V. & Lehmann, J. M. 4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor γ. Proc. Natl Acad. Sci. USA 98, 8880-8884 (2001).
96. Takayanagi, S. et al. Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor γ (ERRγ) with high constitutive activity. Toxicol. Lett. 167, 95-105 (2006).
97. Busch, B. B. et al. Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor α. J. Med. Chem. 47, 5593-5596 (2004).
98. Chao, E. Y. et al. Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRγ. Bioorg. Med. Chem. Lett. 16, 821-824 (2006).
99. Yu, D. D. & Forman, B. M. Identification of an agonist ligand for estrogen-related receptors ERRβ/γ. Bioorg. Med. Chem. Lett. 15, 1311-1313 (2005).
100. Zuercher, W. J. et al. Identification and structure-activity relationship of phenolic acyl hydrazones as selective agonists for the estrogen-related orphan nuclear receptors ERRβ and ERRγ. J. Med. Chem. 48, 3107-3109 (2005).
101. Patch, R. J. et al. Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agents. J. Med. Chem. 54, 788-808 (2011).
102. Vander Heiden, M. G. Targeting cancer metabolism: a therapeutic window opens. Nature Rev. Drug Discov. 10, 671-684 (2011).
103. Lu, X., Peng, L., Lv, M. & Ding, K. Recent advance in the design of small molecular modulators of estrogen-related receptors. Curr. Pharm. Des. 18, 3421-3431 (2012).
104. Narkar, V. A. et al. Exercise and PGC-1α-independent synchronization of type I muscle metabolism and vasculature by ERRγ. Cell Metab. 13, 283-293 (2011).